Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

NCT00019786 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

NIH

Sponsor class

Conditions

Colorectal Cancer
Islet Cell Tumor
Liver Cancer
Metastatic Cancer
Neuroendocrine Carcinoma

Interventions

DRUG: isolated perfusion
DRUG: melphalan
PROCEDURE: conventional surgery

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]